Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mesothelioma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 4 Pancreatic Neoplasms 2 Pain, Postoperative 2 Pain 2 Neoplasms 2 Lung Neoplasms 2 Trauma, Nervous System 1 Thrombosis 1 Synovial Cyst 1 Spondylosis 1 Spondylolisthesis 1 Spinal Stenosis 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1 Sepsis 1 Schwannomatosis 1 Radiculopathy 1 Postoperative Complications 1 Phlebitis 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurilemmoma 1 Multiple Myeloma 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Lipoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Carboplatin 4 pembrolizumab 3 fludarabine 2 Pemetrexed 2 Nivolumab 2 Ipilimumab 2 Cyclophosphamide 2 Cisplatin 2 tremelimumab 1 osimertinib 1 olaparib 1 fludarabine phosphate 1 durvalumab 1 atezolizumab 1 Tumor Burden 1 Thoracoscopy 1 Tablets 1 Saline Solution 1 Quality of Life 1 Observation 1 Magnesium Sulfate 1 Injections 1 Histocompatibility Testing 1 Fluorodeoxyglucose F18 1 Exercise Therapy 1 Combined Modality Therapy 1 Cell- and Tissue-Based Therapy 1 Blood Specimen Collection 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡